4th Quarter - Report

WILLIAMS AND JENSEN, PLLC for NOVARTIS INC

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Tax application of ACA to orphan drugs; H.R. 1393, S. 540, Mobile Workforce State Income Tax Simplification Act of 2017; H.R. 1, Tax Cuts and Jobs Act.

LobbyistCovered position, as disclosed
GEORGE D BAKER —
DENIS DWYER —
CHRISTOPHER W HATCHER —
CHERYL LYNN JAEGER —
NICHOLAS KARELLAS New LA to Senator Christopher Bond; Tax Counsel, Rep Lynn Jenkins
MELINDA M MAXFIELD —
GEORGE OLSEN —
JENNIFER WANANDI —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1 (115th), S. 540 (115th), H.R. 1393 (115th)

Health Issues HCR

Drug importation; drug safety and drug counterfeiting; Authorized generics; Drug company patent settlements; Prescription drug advertising; The Promoting Life Saving New Therapies for Neonates Act; Implementation of the Precision Medicine Initiative; H.R. 1231, RACE for Children Act; S. 934, H.R. 2430, FDA Reauthorization Act of 2017; H.R. 1628, American Health Care Act of 2017; Better Care Reconciliation Act; S. 204, Graham-Cassidy amendment; Trickett Wendler Right to Try Act of 2017; H.R. 878, Right to Try Act of 2017; Legislation concerning therapies for neglected tropical diseases.

LobbyistCovered position, as disclosed
GEORGE D BAKER New —
SUSAN HIRSCHMANN —
MATTHEW B HOEKSTRA —
CHERYL LYNN JAEGER —
ANDREW JONES Legislative Counsel, Rep Hinojosa; Legislative Director and Counsel, Rep. Lugan
NICHOLAS KARELLAS New LA to Senator Christopher Bond; Tax Counsel, Rep Lynn Jenkins
KARINA LYNCH —
MELINDA M MAXFIELD —
ERIN BOOK MULLEN —
GEORGE OLSEN —
DAVID A STARR —
FRANK VLOSSAK LA, Rep. Merrill Cook

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 934 (115th), H.R. 878 (115th), H.R. 2430 (115th), S. 204 (115th), H.R. 1628 (115th), H.R. 1231 (115th)

Medicare/Medicaid MMM

Medicare prescription drug benefit; Rebates for Medicare Part D; Payment policies for Medicare Part B prescription drugs; the Independent Payment Advisory Board (IPAB); repeal of Part D Non-interference provision.

LobbyistCovered position, as disclosed
SUSAN HIRSCHMANN —
CHERYL LYNN JAEGER —
KARINA LYNCH —
MELINDA M MAXFIELD —
GEORGE OLSEN —
DAVID A STARR —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.